Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis - Drug Store News PDF Print
Drug Store News
In a phase-3 trial, Zerenex (ferric citrate) significantly reduced phosphate levels in patients with end-stage kidney disease on dialysis.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.